Financials Beijing Scitop Bio-tech Co., Ltd.

Equities

300858

CNE100004181

Food Processing

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
16.88 CNY +3.18% Intraday chart for Beijing Scitop Bio-tech Co., Ltd. +8.55% -12.54%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Capitalization 1 4,998 4,931 4,605 5,085 4,448 -
Enterprise Value (EV) 1 4,998 4,931 4,605 5,085 4,448 4,448
P/E ratio 44.2 x 44.9 x 41.8 x 55.1 x 35.9 x 26.8 x
Yield - - 0.97% 0.78% 1.24% 1.6%
Capitalization / Revenue 14.7 x 13.5 x 12.5 x 17 x 11 x 8.82 x
EV / Revenue 14.7 x 13.5 x 12.5 x 17 x 11 x 8.82 x
EV / EBITDA 39 x 36.9 x 31.9 x 41.9 x 33.2 x 25 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book 5.36 x 5.1 x 2.71 x 2.93 x 2.45 x 2.31 x
Nbr of stocks (in thousands) 222,798 222,798 223,388 263,495 263,495 -
Reference price 2 22.43 22.13 20.61 19.30 16.88 16.88
Announcement Date 4/22/21 4/25/22 4/18/23 4/24/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 308.1 339.2 364.6 369.2 299.2 403 504
EBITDA 1 - 128.3 133.7 144.4 121.4 134 178
EBIT 1 - 117.7 124.7 127.6 102.6 138 183
Operating Margin - 34.71% 34.2% 34.56% 34.29% 34.24% 36.31%
Earnings before Tax (EBT) 1 - 113.2 124.2 125.7 102 138 183
Net income 1 - 96.58 109.5 109.9 93.48 123 166
Net margin - 28.48% 30.04% 29.77% 31.24% 30.52% 32.94%
EPS 2 0.5593 0.5074 0.4933 0.4933 0.3500 0.4700 0.6300
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - - 0.2000 0.1500 0.2100 0.2700
Announcement Date 7/6/20 4/22/21 4/25/22 4/18/23 4/24/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3
Net sales 1 10.72
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income -
Net margin -
EPS 2 0.1867
Dividend per Share -
Announcement Date 1/16/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - 15.3% 11.5% 11.1% 5.45% 6.9% 8.8%
ROA (Net income/ Total Assets) - - - 7.76% - 6.6% 8.4%
Assets 1 - - - 1,416 - 1,864 1,976
Book Value Per Share 2 - 4.190 4.340 7.590 6.580 6.890 7.310
Cash Flow per Share 2 - 0.3000 0.4900 0.6600 0.4100 0.4100 0.5200
Capex 1 - - 67.6 84.2 178 33 8
Capex / Sales - - 18.53% 22.8% 59.62% 8.19% 1.59%
Announcement Date 7/6/20 4/22/21 4/25/22 4/18/23 4/24/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.88 CNY
Average target price
17.67 CNY
Spread / Average Target
+4.68%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300858 Stock
  4. Financials Beijing Scitop Bio-tech Co., Ltd.